Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,108 | 20,006 | 19,760 | 19,529 | 19,964 |
| Receivables | 23,159 | 23,526 | 29,925 | 29,403 | 29,882 |
| Inventories | 11,739 | 12,141 | 13,193 | 13,001 | 12,966 |
| Other current assets | 0 | 1,121 | 1,003 | 1,333 | 749 |
| TOTAL | $60,738 | $61,891 | $71,130 | $71,371 | $70,599 |
| Non-Current Assets | |||||
| PPE Net | 692 | 693 | 967 | 1,127 | 1,722 |
| Intangibles | 51,205 | 52,453 | 54,082 | 55,711 | 57,341 |
| Other Non-Current Assets | 3,196 | 3,058 | 2,684 | 3,040 | 3,226 |
| TOTAL | $55,093 | $56,204 | $57,733 | $59,878 | $62,289 |
| Total Assets | $115,831 | $118,095 | $128,863 | $131,249 | $132,888 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,127 | 4,252 | 16,716 | 1,065 | 1,277 |
| Accounts payable and accrued liabilities | 13,513 | 10,314 | 10,475 | 10,473 | 14,466 |
| Accrued Expenses | 33,723 | 38,143 | 44,091 | 43,413 | 40,730 |
| Other current liabilities | 7,889 | 8,962 | 12,407 | 9,236 | 8,990 |
| TOTAL | $61,252 | $62,228 | $83,689 | $64,187 | $65,463 |
| Non-Current Liabilities | |||||
| Long Term Debt | 10,430 | 10,877 | N/A | 14,978 | 14,842 |
| Other Non-Current Liabilities | 14,323 | 17,274 | 14,397 | 19,231 | 20,416 |
| TOTAL | $24,753 | $28,151 | $14,397 | $34,209 | $35,258 |
| Total Liabilities | $86,005 | $90,379 | $98,086 | $98,396 | $100,721 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,149 | 6,149 | 5,568 | 5,568 | 5,567 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -318,499 | -319,973 | -315,356 | -312,469 | -312,249 |
| TOTAL | $29,826 | $27,716 | $30,777 | $32,853 | $32,167 |
| Total Liabilities And Equity | $115,831 | $118,095 | $128,863 | $131,249 | $132,888 |